{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:17:57Z","timestamp":1789676277161,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2431055"],"award-info":[{"award-number":["W2431055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2023YFC3404101"],"award-info":[{"award-number":["2023YFC3404101"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25ZR1401313"],"award-info":[{"award-number":["25ZR1401313"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-KJFZMSX0044"],"award-info":[{"award-number":["CSTB2024NSCQ-KJFZMSX0044"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phymed.2026.158350","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:06:11Z","timestamp":1779807971000},"page":"158350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cepharanthine triggers immunogenic cell death in solid tumors by suppressing protein kinase C zeta\u2013mediated poly(ADP-ribose) polymerase 1 expression and synergizes with immunotherapy"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6346-5018","authenticated-orcid":false,"given":"Kaiwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-9667","authenticated-orcid":false,"given":"Bin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158350_bib0001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2026.158350_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1390263","article-title":"Emerging role of immunogenic cell death in cancer immunotherapy","volume":"15","author":"Arimoto","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158350_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176839","article-title":"Cepharanthine triggers ferroptosis through inhibition of NRF2 for robust ER stress against lung cancer","volume":"979","author":"Bai","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158350_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152956","article-title":"Cepharanthine: an update of its mode of action, pharmacological properties and medical applications","volume":"62","author":"Bailly","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158350_bib0005","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12890-024-03250-z","article-title":"Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization","volume":"24","author":"Bao","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.phymed.2026.158350_bib0006","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2026.158350_bib0007","first-page":"229","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2026.158350_bib0008","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1172\/JCI123319","article-title":"PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer","volume":"129","author":"Chabanon","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2026.158350_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41423-022-00956-0","article-title":"Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis","volume":"20","author":"Chen","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phymed.2026.158350_bib0010","article-title":"Tumor microenvironment-triggered aggregated magnetic nanoparticles for reinforced image-guided immunogenic chemotherapy","volume":"6","author":"Chen","year":"2019","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.phymed.2026.158350_bib0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phymed.2026.158350_bib0012","article-title":"Application of immune checkpoint inhibitors in cancer","volume":"6","author":"Chen","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.phymed.2026.158350_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157648","article-title":"Cucurbitacin I induces immunogenic cell death and synergistically potentiates cisplatin efficacy in epithelial ovarian cancer","volume":"150","author":"Dai","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158350_bib0014","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.biochi.2005.02.009","article-title":"A role for PKCzeta in the LPS-induced translocation NF-kappaB p65 subunit in cultured myometrial cells","volume":"87","author":"Dallot","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.phymed.2026.158350_bib0015","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"De Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158350_bib0016","first-page":"181","article-title":"The potential antitumor effects of capsaicin","volume":"68","author":"Diaz-Laviada","year":"2014","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.phymed.2026.158350_bib0017","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/j.1460-2075.1994.tb06578.x","article-title":"Zeta PKC induces phosphorylation and inactivation of I kappa b-alpha in vitro","volume":"13","author":"Diaz-Meco","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.phymed.2026.158350_bib0018","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-065X.2012.01093.x","article-title":"The atypical PKCs in inflammation: nF-kappaB and beyond","volume":"246","author":"Diaz-Meco","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phymed.2026.158350_bib0019","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2026.158350_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","article-title":"Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: a phase 1 study","volume":"5","author":"Emens","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.phymed.2026.158350_bib0021","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158350_bib0022","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1363139","article-title":"Trial watch: adoptively transferred cells for anticancer immunotherapy","volume":"6","author":"Fournier","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.phymed.2026.158350_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.phymed.2026.158350_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phymed.2026.158350_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2019.12.018","article-title":"Tumor immunology and tumor evolution: intertwined histories","volume":"52","author":"Galon","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2026.158350_bib0026","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1159\/000471234","article-title":"Cepharanthine induces autophagy, apoptosis and cell cycle arrest in breast cancer cells","volume":"41","author":"Gao","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.phymed.2026.158350_bib0027","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fimmu.2015.00588","article-title":"Molecular and translational classifications of DAMPs in immunogenic cell death","volume":"6","author":"Garg","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158350_bib0028","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12672-025-02052-x","article-title":"Research trends and highlights in PD-1\/PD-L1 inhibitor immunotherapy in lung cancer: a bibliometric analysis","volume":"16","author":"Gu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.phymed.2026.158350_bib0029","article-title":"Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity","volume":"6","author":"Gui","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.phymed.2026.158350_bib0030","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.jchromb.2010.08.026","article-title":"Simple, sensitive and rapid HPLC-MS\/MS method for the determination of cepharanthine in human plasma","volume":"878","author":"Hao","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.phymed.2026.158350_bib0031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/CMAR.S40601","article-title":"Presentation and management of docetaxel-related adverse effects in patients with breast cancer","volume":"6","author":"Ho","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.phymed.2026.158350_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101928","article-title":"PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.phymed.2026.158350_bib0033","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phymed.2026.158350_bib0034","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158350_bib0035","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/MCB.19.3.2180","article-title":"Activation of IkappaB kinase beta by protein kinase C isoforms","volume":"19","author":"Lallena","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phymed.2026.158350_bib0036","doi-asserted-by":"crossref","first-page":"24124","DOI":"10.1074\/jbc.M601905200","article-title":"Protein kinase czeta is up-regulated in osteoarthritic cartilage and is required for activation of NF-kappaB by tumor necrosis factor and interleukin-1 in articular chondrocytes","volume":"281","author":"Lavallie","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2026.158350_bib0037","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1200\/JCO.2016.72.1340","volume":"35","author":"Lee","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158350_bib0038","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1158\/1078-0432.CCR-20-3546","article-title":"An open-label, multicenter, single-arm, phase II study of fluzoparib in patients with germline BRCA1\/2 mutation and platinum-sensitive recurrent ovarian cancer","volume":"27","author":"Li","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158350_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248933","article-title":"Pharmacological effects and clinical prospects of cepharanthine","volume":"27","author":"Liang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2026.158350_bib0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr5861","article-title":"Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy","volume":"17","author":"Liu","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phymed.2026.158350_bib0041","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13020-019-0270-9","article-title":"Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine","volume":"14","author":"Luo","year":"2019","journal-title":"Chin. Med."},{"key":"10.1016\/j.phymed.2026.158350_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.06.013","article-title":"Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors","volume":"187","author":"Luo","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158350_bib0043","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"Gammah2ax: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"Mah","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.phymed.2026.158350_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172472","article-title":"Alkaloids for cancer prevention and therapy: current progress and future perspectives","volume":"858","author":"Mondal","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158350_bib0045","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/sj.cdd.4401823","article-title":"PKCzeta at the crossroad of NF-kappaB and jak1\/stat6 signaling pathways","volume":"13","author":"Moscat","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phymed.2026.158350_bib0046","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in patients with advanced triple-negative breast cancer: phase ib keynote-012 study","volume":"34","author":"Nanda","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158350_bib0047","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40364-024-00594-w","article-title":"Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation","volume":"12","author":"Orlikova-Boyer","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.phymed.2026.158350_bib0048","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2026.158350_bib0049","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.phymed.2026.158350_bib0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fonc.2013.00232","article-title":"Chemoresistance and cancer-related inflammation: two hallmarks of cancer connected by an atypical link, PKCzeta","volume":"3","author":"Rimessi","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phymed.2026.158350_bib0051","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4161\/cc.11.5.19520","article-title":"The selective inhibition of nuclear PKCzeta restores the effectiveness of chemotherapeutic agents in chemoresistant cells","volume":"11","author":"Rimessi","year":"2012","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.phymed.2026.158350_bib0052","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1349-7006.2010.01572.x","article-title":"Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB","volume":"101","author":"Seubwai","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2026.158350_bib0053","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158350_bib0054","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41401-021-00715-3","article-title":"Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis","volume":"43","author":"Shen","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2026.158350_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4110\/in.2016.16.1.75","article-title":"Immunogenic cell death induced by ginsenoside Rg3: significance in dendritic cell-based anti-tumor immunotherapy","volume":"16","author":"Son","year":"2016","journal-title":"Immune Netw."},{"key":"10.1016\/j.phymed.2026.158350_bib0056","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/ijc.24521","article-title":"Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway","volume":"125","author":"Takahashi-Makise","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2026.158350_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.816642","article-title":"Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications","volume":"13","author":"Wanderley","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158350_bib0058","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4049\/jimmunol.1101373","article-title":"New insights on OX40 in the control of T cell immunity and immune tolerance in vivo","volume":"188","author":"Xiao","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2026.158350_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107659","article-title":"Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases","volume":"217","author":"Xu","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2026.158350_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108726","article-title":"Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and pi3k\/akt\/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells","volume":"310","author":"Xu","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2026.158350_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phymed.2026.158350_bib0062","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3999\/jscpt.20.741","article-title":"Pharmacokinetic disposition of cepharanthin following single and multiple intravenous doses in healthy subjects","volume":"20","author":"Yasuda","year":"1989","journal-title":"Jpn. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2026.158350_bib0063","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3999\/jscpt.20.735","article-title":"Pharmacokinetic study of cepharanthin following single oral doses in healthy subjects","volume":"20","author":"Yasuda","year":"1989","journal-title":"Jpn. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2026.158350_bib0064","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/d41573-019-00182-w","article-title":"Trends in clinical development for PD-1\/PD-L1 inhibitors","volume":"19","author":"Yu","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2026.158350_bib0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.seminoncol.2023.09.005","article-title":"PARP inhibitors: a review of the pharmacology, pharmacokinetics, and pharmacogenetics","volume":"51","author":"Zeng","year":"2024","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.phymed.2026.158350_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155828","article-title":"Immunogenic cell death inducers for cancer therapy: an emerging focus on natural products","volume":"132","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158350_bib0067","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fimmu.2020.00331","article-title":"Low-dose gemcitabine treatment enhances immunogenicity and natural killer cell-driven tumor immunity in lung cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158350_bib0068","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phymed.2026.158350_bib0069","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41420-025-02360-9","article-title":"Macrocarpal I induces immunogenic cell death and synergizes with immune checkpoint inhibition by targeting tubulin and PARP1 in colorectal cancer","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phymed.2026.158350_bib0070","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.14395","article-title":"Pembrolizumab: a reliable second-line treatment option for advanced esophageal cancer","volume":"13","author":"Zheng","year":"2022","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.phymed.2026.158350_bib0071","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phymed.2026.158350_bib0072","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bcp.2008.12.005","article-title":"Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance","volume":"77","author":"Zhou","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158350_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115877","article-title":"ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer","volume":"261","author":"Zuo","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326005829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326005829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:14:47Z","timestamp":1783016087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326005829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":73,"alternative-id":["S0944711326005829"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158350","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cepharanthine triggers immunogenic cell death in solid tumors by suppressing protein kinase C zeta\u2013mediated poly(ADP-ribose) polymerase 1 expression and synergizes with immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158350"}}